Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases? (Q39872559)

15 September 2017

title

Should patients with chronic obstructive pulmonary disease be vaccinated against pneumococcal diseases? (English)

1 reference

chronic obstructive pulmonary disease

15 September 2017

main subject

1 reference

Jacques Gaillat

1

1 reference

15 September 2017

publication date

1 December 2009

1 reference

Expert Review of Respiratory Medicine

15 September 2017

published in

1 reference

15 September 2017

volume

3

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

585-596

1 reference

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

15 September 2017

cites work

1 reference

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

Prevalence of obstructive lung disease in a general population sample: the NICECOPD study

21 January 2018

1 reference

Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

21 January 2018

1 reference

Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort

21 January 2018

1 reference

The burden of community-acquired pneumonia in seniors: results of a population-based study

21 January 2018

1 reference

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

Infectious etiology of acute exacerbations of chronic bronchitis

21 January 2018

1 reference

Acute exacerbation of chronic bronchitis: disease-specific issues that influence the cost-effectiveness of antimicrobial therapy

21 January 2018

1 reference

Infection in the pathogenesis and course of chronic obstructive pulmonary disease

21 January 2018

1 reference

A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia.

21 January 2018

1 reference

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

21 January 2018

1 reference

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

21 January 2018

1 reference

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

21 January 2018

1 reference

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

21 January 2018

1 reference

Diagnosis of Streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: clinical comparison of pneumococcal PCR and urinary antigen detection

21 January 2018

1 reference

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials

21 January 2018

1 reference

Effectiveness of pneumococcal polysaccharide vaccine in older adults

21 January 2018

1 reference

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

21 January 2018

1 reference

Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination

21 January 2018

1 reference

Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly.

21 January 2018

1 reference

Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency.

21 January 2018

1 reference

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study

21 January 2018

1 reference

Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma.

21 January 2018

1 reference

Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients.

21 January 2018

1 reference

Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease

21 January 2018

1 reference

Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia

21 January 2018

1 reference

Guidelines for the management of adult lower respiratory tract infections

21 January 2018

1 reference

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).

21 January 2018

1 reference

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

21 January 2018

1 reference

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

21 January 2018

1 reference

The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004

21 January 2018

1 reference

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

21 January 2018

1 reference

Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

21 January 2018

1 reference

Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies

21 January 2018

1 reference

Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection

21 January 2018

1 reference

Response to pneumococcal vaccine in chronic obstructive lung disease—The effect of ongoing, systemic steroid treatment

21 January 2018

1 reference

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.09.53

1 reference

15 September 2017

1 reference